Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencySat, 08 Jun 2024 01:17:27 +0200Fri, 05 Apr 2024 16:50:00 +0200Human medicines European public assessment report (EPAR): Strimvelis, autologous CD34+ enriched cell fraction that contains CD34+ cells transduced with retroviral vector that encodes for the human ADA cDNA sequence, Date of authorisation: 26/05/2016, Revision: 10, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/strimvelisHuman medicines European public assessment report (EPAR): Strimvelis, autologous CD34+ enriched cell fraction that contains CD34+ cells transduced with retroviral vector that encodes for the human ADA cDNA sequence, Date of authorisation: 26/05/2016, Revision: 10, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/strimvelisFri, 05 Apr 2024 16:50:00 +0200Human medicineStrimvelis : EPAR - Summary for the publichttps://www.ema.europa.eu/system/files/documents/overview/wc500208202_en.pdfStrimvelis : EPAR - Summary for the publichttps://www.ema.europa.eu/system/files/documents/overview/wc500208202_en.pdfWed, 08 Jun 2016 02:00:00 +0200Human medicine